de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Poster

Metabolism of avian designer cells during influenza and MVA production

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons86389

Lohr,  V.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86444

Rath,  A.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86303

Genzel,  Y.
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons86448

Reichl,  U.
Otto-von-Guericke-Universität Magdeburg;
Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Lohr, V., Rath, A., Genzel, Y., Jordan, I., Sandig, V., & Reichl, U. (2008). Metabolism of avian designer cells during influenza and MVA production. Poster presented at Vaccine Technology II, Albufeira, Portugal.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0013-95D3-6
Abstract
As alternatives to well-established cell lines such as Vero or BHK cultures new designer cells are under consideration for vaccine production. Potential candidates are ProBioGen’s avian cells (AGE1.CR and AGE1.CR.pIX)1. Both cell lines grow in suspension in serum free medium (SFM) and can be productively infected with different influenza strains2 and MVA3. To identify optimal cultivation conditions for vaccine production, the cell lines must be characterized first. Metabolic data together with cell density and virus titers were evaluated in this work for different process conditions involving media (SFM1, SFM2), cultivation vessels (T-flasks, roller bottles, wave bioreactor) and infection conditions. In the following, we present data for the cultivation and infection of both CR and CR.pIX cells with influenza and MVA.